Yang, L.,
Luo, W.,
Zhang, Q,
Hong, S.,
Wang, Y.,
Samorodov, A.V.,
Chattipakorn, N.,
Pavlov, V.N.,
Liang, G. (2021) ). The pharmacological
effect of CAR was further
evaluated in both LPS-stimulated macrophages and ALI mice model. Results
Asadullina, D.D.,
Gilyazova, I.R.,
Ivanova, E.A.,
Izmailova, S.M.,
Gilyazova, G.R.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2024) RNA-146a can be used to create a panel of molecular markers for
evaluating the
effectiveness of immune
Jun, Yang,
Wang, Minxiu,
Xu, Yulan,
Liao, Jing,
Li, Xiang,
Zhou, Ying,
Dai, Jintian,
Li, Xiaobo,
Chen, Pan,
Chen, Gaozhi,
Cho, Won-Jea,
Chattipakorn, Nipon,
Samorodov, A.V,
Pavlov, V.N,
Wang, Yi,
Liang, Guang,
Tang, Qidong (2023) is considered to be a promising method for the
treatment of inflammation-related diseases. In this study, a
Klen, E.E.,
Nikitina, I.L.,
Khaliullin, F.A.,
Shepilova, S.O.,
Nikitina, E.A.,
Gaisina, G.G.,
Samorodov, A.V.,
Pavlov, V.N. (2024) , tumorigenicity, reproductive
effects, irritating
effects), low toxicity (class IV-V), and acceptable oral
Chen, P.,
Yu, Y.,
Su, S.,
Du, Z.,
Cai, B.,
Sun, X.,
Chattipakorn, N.,
Samorodov, A.V.,
Pavlov, V.N.,
Tang, Q.,
Cho, W.-J.,
Liang, G. (2023) %–40%. There is an unmet
clinical need owing to limited
treatment strategies and little clinical benefit. The pathology
Успехи робот-ассистированной цистэктомии в лечении мышечно-инвазивного рака мочевого пузыряPavlov, V.N.,
Urmantsev, M.F.,
Bakeev, M.R.,
Павлов, В.Н.,
Урманцев, М.Ф.,
Бакеев, М.Р. (2022) The success of robot-assisted cystectomy in the
treatment of muscle-invasive bladder cancer
FENG, C.,
GONG, R.,
ZHENG, Q.Y.,
YANG, G.G.,
HE, M.Y.,
LEI, H.,
LI, X.D.,
ZHANG, L.,
XU, Z.H.,
LIU, S.Z.,
YU, M.X.,
MA, T.S.,
GAO, M.Q.,
BAMBA, D.,
IDIYATULLINA, E.T.,
ZAGIDULLIN, N.SH.,
PAVLOV, V.N.,
XU, C.Q.,
YUAN, Y.,
YANG, L. (2019) anti-tumor
effects of combined
treatments of ATO and blue LED on human OS cells, which were associated
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) in DCM and to test the therapeutic
effects of MD2 inhibitor C30 on DCM. Streptozotocin (STZ) was used